224 related articles for article (PubMed ID: 22964878)
21. Mammalian Antimicrobial Peptides: Promising Therapeutic Targets Against Infection and Chronic Inflammation.
Dutta P; Das S
Curr Top Med Chem; 2016; 16(1):99-129. PubMed ID: 26139111
[TBL] [Abstract][Full Text] [Related]
22. No country for old antibiotics! Antimicrobial peptides (AMPs) as next-generation treatment for skin and soft tissue infection.
Răileanu M; Borlan R; Campu A; Janosi L; Turcu I; Focsan M; Bacalum M
Int J Pharm; 2023 Jul; 642():123169. PubMed ID: 37356506
[TBL] [Abstract][Full Text] [Related]
23. Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces.
Costa F; Carvalho IF; Montelaro RC; Gomes P; Martins MC
Acta Biomater; 2011 Apr; 7(4):1431-40. PubMed ID: 21056701
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial peptides (AMPs): The quintessential 'offense and defense' molecules are more than antimicrobials.
Patel S; Akhtar N
Biomed Pharmacother; 2017 Nov; 95():1276-1283. PubMed ID: 28938518
[TBL] [Abstract][Full Text] [Related]
25. The expanding scope of antimicrobial peptide structures and their modes of action.
Nguyen LT; Haney EF; Vogel HJ
Trends Biotechnol; 2011 Sep; 29(9):464-72. PubMed ID: 21680034
[TBL] [Abstract][Full Text] [Related]
26. Potential applications of antimicrobial peptides and their mimics in combating caries and pulpal infections.
Mai S; Mauger MT; Niu LN; Barnes JB; Kao S; Bergeron BE; Ling JQ; Tay FR
Acta Biomater; 2017 Feb; 49():16-35. PubMed ID: 27845274
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory Effects of Antimicrobial Peptides on Lipopolysaccharide-Induced Inflammation.
Sun Y; Shang D
Mediators Inflamm; 2015; 2015():167572. PubMed ID: 26612970
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial peptide production and plant-based expression systems for medical and agricultural biotechnology.
Holaskova E; Galuszka P; Frebort I; Oz MT
Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1005-23. PubMed ID: 25784148
[TBL] [Abstract][Full Text] [Related]
29. Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects.
Padhi A; Sengupta M; Sengupta S; Roehm KH; Sonawane A
Tuberculosis (Edinb); 2014 Jul; 94(4):363-73. PubMed ID: 24813349
[TBL] [Abstract][Full Text] [Related]
30. Antimicrobial peptides: review of their application in musculoskeletal infections.
Stallmann HP; Faber C; Nieuw Amerongen AV; Wuisman PI
Injury; 2006 May; 37 Suppl 2():S34-40. PubMed ID: 16651070
[TBL] [Abstract][Full Text] [Related]
31. A cutaneous gene therapy approach to treat infection through keratinocyte-targeted overexpression of antimicrobial peptides.
Carretero M; Del Río M; García M; Escámez MJ; Mirones I; Rivas L; Balague C; Jorcano JL; Larcher F
FASEB J; 2004 Dec; 18(15):1931-3. PubMed ID: 15456737
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial peptides: premises and promises.
Reddy KV; Yedery RD; Aranha C
Int J Antimicrob Agents; 2004 Dec; 24(6):536-47. PubMed ID: 15555874
[TBL] [Abstract][Full Text] [Related]
33. Innate immune defense system of the skin.
Afshar M; Gallo RL
Vet Dermatol; 2013 Feb; 24(1):32-8.e8-9. PubMed ID: 23331677
[TBL] [Abstract][Full Text] [Related]
34. Human antimicrobial peptides in ocular surface defense.
Mohammed I; Said DG; Dua HS
Prog Retin Eye Res; 2017 Nov; 61():1-22. PubMed ID: 28587935
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial Peptides, Infections and the Skin Barrier.
Clausen ML; Agner T
Curr Probl Dermatol; 2016; 49():38-46. PubMed ID: 26844896
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial peptides and alytesin are co-secreted from the venom of the Midwife toad, Alytes maurus (Alytidae, Anura): implications for the evolution of frog skin defensive secretions.
König E; Zhou M; Wang L; Chen T; Bininda-Emonds OR; Shaw C
Toxicon; 2012 Nov; 60(6):967-81. PubMed ID: 22800568
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial peptides - Unleashing their therapeutic potential using nanotechnology.
Gera S; Kankuri E; Kogermann K
Pharmacol Ther; 2022 Apr; 232():107990. PubMed ID: 34592202
[TBL] [Abstract][Full Text] [Related]
38. Cyclic peptides as potential therapeutic agents for skin disorders.
Namjoshi S; Benson HA
Biopolymers; 2010; 94(5):673-80. PubMed ID: 20564043
[TBL] [Abstract][Full Text] [Related]
39. The role of antimicrobial peptides in human skin and in skin infectious diseases.
Schittek B; Paulmann M; Senyürek I; Steffen H
Infect Disord Drug Targets; 2008 Sep; 8(3):135-43. PubMed ID: 18782030
[TBL] [Abstract][Full Text] [Related]
40. Effect of natural L- to D-amino acid conversion on the organization, membrane binding, and biological function of the antimicrobial peptides bombinins H.
Mangoni ML; Papo N; Saugar JM; Barra D; Shai Y; Simmaco M; Rivas L
Biochemistry; 2006 Apr; 45(13):4266-76. PubMed ID: 16566601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
